Medicare Enrolled
Dr. Matthew Kozminski, D.O.
Neurology · Tarentum, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kozminski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kozminski?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kozminski
Dr. Matthew Kozminski is a neurology specialist in Tarentum, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kozminski performed 527 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kozminski received a total of $201,196 from 79 pharmaceutical and/or device companies across 1048 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kozminski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 30% volume in PA
$201,196 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗527
Medicare services
Top 30% in PA for neurology
Not available
Unique patients (not deduplicated)
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth | 132 | $80 | $250 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
98 | $128 | $285 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
92 | $87 | $210 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
47 | $55 | $145 |
| New patient office visit, complex (60-74 min) | 43 | $147 | $434 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
39 | $133 | $405 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
22 | $88 | $355 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
21 | $41 | $885 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
17 | $61 | $250 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
16 | $43 | $900 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$201,196
Total received (2018-2024)
Avg $28,742/year across 7 years
Top 5% in PA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
79
Companies
1,048
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$9,738
2023
$16,532
2022
$26,005
2021
$39,658
2020
$24,293
2019
$34,819
2018
$50,150
Payments by company (2024)
ABBVIE INC.
$7,790
GENZYME CORPORATION
$339
Alexion Pharmaceuticals, Inc.
$274
Eisai Inc.
$193
PFIZER INC.
$161
Teva Pharmaceuticals USA, Inc.
$145
Genentech USA, Inc.
$96
Lundbeck LLC
$73
JAZZ PHARMACEUTICALS INC.
$67
SK Life Science, Inc.
$45
Neurocrine Biosciences, Inc.
$42
Lilly USA, LLC
$42
Otsuka America Pharmaceutical, Inc.
$40
Boston Scientific Corporation
$39
Amgen Inc.
$35
Novartis Pharmaceuticals Corporation
$31
Grifols USA, LLC
$29
Takeda Pharmaceuticals U.S.A., Inc.
$27
ANI Pharmaceuticals, Inc.
$27
HARMONY BIOSCIENCES LLC
$26
Xeris Pharmaceuticals, Inc.
$20
CSL Behring
$19
MITSUBISHI TANABE PHARMA AMERICA, INC.
$19
Sumitomo Pharma America, Inc.
$19
Biogen, Inc.
$19
ACADIA Pharmaceuticals Inc
$18
UCB, Inc.
$17
ARGENX US, INC.
$16
Janssen Pharmaceuticals, Inc
$15
Acorda Therapeutics, Inc
$15
GE HEALTHCARE
$14
Celgene Corporation
$14
Abbott Laboratories
$13
Top 3 companies account for 86.3% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$62,033
GENZYME CORPORATION
$30,045
ABBVIE INC.
$26,819
Allergan, Inc.
$18,927
Supernus Pharmaceuticals, Inc.
$16,695
Biohaven Pharmaceuticals, Inc.
$16,488
AbbVie Inc.
$9,925
Biohaven Pharmaceutical Holding Company Ltd.
$7,543
Biogen, Inc.
$1,107
Avanir Pharmaceuticals, Inc.
$856
Teva Pharmaceuticals USA, Inc.
$760
Novartis Pharmaceuticals Corporation
$686
Promius Pharma LLC
$632
UCB, Inc.
$620
Alexion Pharmaceuticals, Inc.
$513
Janssen Pharmaceuticals, Inc
$489
Lundbeck LLC
$483
PFIZER INC.
$416
Allergan Inc.
$409
Lilly USA, LLC
$393
Mallinckrodt Hospital Products Inc.
$353
Genentech USA, Inc.
$346
EMD Serono, Inc.
$314
ACADIA Pharmaceuticals Inc
$302
US WorldMeds, LLC
$296
Mallinckrodt Enterprises LLC
$279
Neurocrine Biosciences, Inc.
$268
Neurelis, Inc.
$258
JAZZ PHARMACEUTICALS INC.
$241
Eisai Inc.
$233
Kyowa Kirin, Inc.
$187
Celgene Corporation
$164
Acorda Therapeutics, Inc
$147
Amneal Pharmaceuticals LLC
$145
Otsuka America Pharmaceutical, Inc.
$143
SK Life Science, Inc.
$142
MITSUBISHI TANABE PHARMA AMERICA, INC.
$135
Bausch Health US, LLC
$112
ARGENX US, INC.
$94
BANNER LIFE SCIENCES, LLC
$80
Adamas Pharmaceuticals, Inc.
$70
CSL Behring
$66
Sunovion Pharmaceuticals Inc.
$60
Ipsen Biopharmaceuticals, Inc
$55
Mallinckrodt LLC
$53
ANI Pharmaceuticals, Inc.
$48
Grifols USA, LLC
$45
Boston Scientific Corporation
$39
GE HealthCare
$38
Avion Pharmaceuticals
$35
Arbor Pharmaceuticals, Inc.
$34
Azurity Pharmaceuticals, Inc.
$33
GE HEALTHCARE
$31
Collegium Pharmaceutical, Inc.
$31
Harmony Biosciences LLC
$31
EISAI INC.
$30
Upsher-Smith Laboratories LLC
$28
Takeda Pharmaceuticals U.S.A., Inc.
$27
HARMONY BIOSCIENCES LLC
$26
Abbott Laboratories
$26
LivaNova USA, Inc.
$23
Xeris Pharmaceuticals, Inc.
$20
MDD US Operations, LLC
$20
Merck Sharp & Dohme LLC
$20
UPSHER-SMITH LABORATORIES LLC
$20
Jazz Pharmaceuticals Inc.
$19
Sumitomo Pharma America, Inc.
$19
TG THERAPEUTICS, INC.
$18
Banner Life Sciences, LLC
$18
ARBOR PHARMACEUTICALS, INC.
$17
Impax Laboratories, Inc.
$16
AbbVie, Inc.
$16
Amylyx Pharmaceuticals, Inc.
$15
Mylan Pharmaceuticals Inc.
$15
Almatica Pharma LLC
$15
Greenwich Biosciences, Inc.
$15
SANOFI-AVENTIS U.S. LLC
$13
Horizon Therapeutics plc
$13
Kedrion Biopharma, Inc.
$3
Top 3 companies account for 59.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Albuked · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · COMIRNATY · COPAXONE · DISEASE STATE · DYSPORT · Deep Brain Stimulation · Dhivy · Duopa · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Evrysdi · Fycompa · GAUCHER-DISEASE · GOCOVRI · Gamunex-C · Glatiramer Acetate · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · JOT DX · KESIMPTA · KEVEYIS · LEMTRADA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAPRELAN · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · ONZETRA Xsail · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · RELYVRIO · REXULTI · RYTARY · Rebif · SOLIRIS · SUNOSI · TECFIDERA · TOSYMRA · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XARELTO · XYWAV · Xadago · ZEPOSIA · Zembrace
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
131
County median income
$76,393
Nearest hospital to ZIP centroid (approximate)
ALLEGHENY VALLEY HOSPITAL
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kozminski is a clinical cardiology specialist, with above-average Medicare volume (top 30% in PA), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kozminski experienced with follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth?
Based on Medicare claims data, Dr. Kozminski performed 132 follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kozminski receive payments from pharmaceutical companies?
Yes. Dr. Kozminski received a total of $201,196 from 79 companies across 1,048 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kozminski's costs compare to other neurologists in Tarentum?
Dr. Kozminski's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kozminski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Tarentum
Browse neurologists in Tarentum ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in PA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in PA
Which PA neurologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology